Articles

Everolimus and Sunitinib Recommended for Approval in Pancreatic Neuroendocrine Tumors

By Garrett Melton

FDA Approvals

TOP - Daily

Get TOP in Your Inbox!

Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.

I have reviewed and consent to the terms of TOP Privacy Policy, and TOP has my permission to retain my information in its database, and to forward pertinent communications to me.